RxSight, Inc.

RxSight, Inc.

RXST · Nasdaq

RxSight, Inc. (RXST) is a Medical devices company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for RxSight, Inc. in 2026. The next earnings report is expected on November 11, 2026.

Earnings calendar

Next earnings date

11 Nov 2026

In 82 days

EPS estimate

-0.27

Revenue estimate

35.1M

Past earnings

05 Aug 2026
EPS actual
-0.29 (+12.0%)
estimate -0.33
Revenue actual
33.7M (+3.7%)
estimate 32.5M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
06 May 2026
EPS actual
-0.38 (-27.1%)
estimate -0.30
Revenue actual
30.9M (+3.8%)
estimate 29.8M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
25 Feb 2026
EPS actual
-0.22 (+34.3%)
estimate -0.33
Revenue actual
32.6M (+8.1%)
estimate 30.2M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Latest earnings analysis

RxSight beat consensus estimates on both EPS and revenue, posting EPS of -$0.29 versus an estimate of -$0.3294 and revenue of $33.74 million, which exceeded estimates by 3.7%. In the prior quarter EPS missed expectations while revenue came in ahead of estimates.

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.

Sector
Healthcare
Industry
Medical devices
Country
United States
Exchange
Nasdaq
CEO
Ronald Kurtz
Employees
498
IPO date
30 Jul 2021
ISIN
US78349D1072
Website
rxsight.com

Frequently asked questions

When does RxSight, Inc. (RXST) next report earnings?

RxSight, Inc. (RXST) is scheduled to report earnings on November 11, 2026.

What was RxSight, Inc.'s most recent earnings date?

RxSight, Inc. (RXST) last reported earnings on August 5, 2026.

Where is RxSight, Inc. stock listed?

RxSight, Inc. (RXST) is listed on Nasdaq.